| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/17/2009 | US20090233946 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation |
| 09/17/2009 | US20090233937 Fused heterocyclic compound |
| 09/17/2009 | US20090233936 Fused Aminopiperidines as Dipeptidyl Peptidase-4 Inhibitors for the Treatment or Prevention of Diabetes |
| 09/17/2009 | US20090233907 Pyridopyrimidine Derivatives and Their Use as PDE4 Inhibitors |
| 09/17/2009 | US20090233906 Imidazoazepinone compounds |
| 09/17/2009 | US20090233903 Azetidine and cyclobutane derivatives as jak inhibitors |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090233207 Pyrazolotriazole compound and electrophotographic toner |
| 09/17/2009 | CA2750859A1 The compounds as the estrogen related receptors modulators and the uses thereof |
| 09/17/2009 | CA2722479A1 Rna-selective hybridization reagent and use of the same |
| 09/17/2009 | CA2718403A1 Inhibitors of the bmp signaling pathway |
| 09/17/2009 | CA2718271A1 Azetidine and cyclobutane derivatives as jak inhibitors |
| 09/17/2009 | CA2718252A1 Bicyclic pyrrole compound |
| 09/17/2009 | CA2716679A1 Amido-thiophene compounds and their use |
| 09/16/2009 | EP2100893A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 09/16/2009 | EP2099804A1 Compounds for the treatment of hepatitis c |
| 09/16/2009 | EP2099803A1 Heterobicyclic matrix metalloprotease inhibitors |
| 09/16/2009 | EP2099802A2 Substituted quinazolines |
| 09/16/2009 | EP2099801A1 Imidazoý1,5-b¨pyridazinamido ligands and their complexes |
| 09/16/2009 | EP2099800A1 7-substituted purine derivatives for immunosuppression |
| 09/16/2009 | EP2099796A1 Aza-indolyl compounds and methods of use |
| 09/16/2009 | EP2099761A2 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099747A1 Radiolabelling via fluorination of aziridines |
| 09/16/2009 | EP2099447A1 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 09/16/2009 | EP2099304A2 Carboranylporphyrins and uses thereof |
| 09/16/2009 | EP1910383B1 Benzodiazepine derivatives and uses thereof in medical field |
| 09/16/2009 | EP1704157B1 Metal complexes having vitamin b12 as a ligand |
| 09/16/2009 | CN101535315A Heterocyclic compounds useful as anabolic agents for livestock animals |
| 09/16/2009 | CN101535314A Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a] pirimidin-6-one and 8-piperidinyl-2-pyrimidi nyl-pyrimido[1,2,-a]pyrimidin-6-one derivatives |
| 09/16/2009 | CN101535313A 3-aminocarbonyi-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 09/16/2009 | CN101535312A 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors |
| 09/16/2009 | CN101535311A Salts of pyrrolopyrimidinone derivatives and process for preparing the same |
| 09/16/2009 | CN101531663A Method for preparing methyl pheophorbide-A from water-blooming cyanobacteria |
| 09/16/2009 | CN101531662A (3aS, 4aR, 8aR)-3a-(trifluoromethyl)+hydrogen-1H-benzo (d) pyrrole (1, 2-a)-imidazole-1-ketone and synthetic method thereof |
| 09/16/2009 | CN100540553C Optical dye of phthalocyanine derivative, and application in recording medium |
| 09/16/2009 | CN100540548C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/15/2009 | US7589201 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 09/15/2009 | US7589115 2-[5-[4-(4-amino-pyrimidin-5-yl)-benzyl]-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonylamino]-N-(2-hydroxy-ethyl)-propionamide; inhibit interaction of CAMs and Leukointegrins; are metabolized at a rate that is not overly rapid; antiinflammatories |
| 09/15/2009 | US7589102 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/15/2009 | US7589097 Using compounds such as 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine for therapy of Parkinson's disease; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589093 2,3-Dimethylindolo[2,3-b]quinoxaline-6-yl-acetamide; 9-Chloro-2,3-dimethyl-6-(aminoethylamino-2-oxoethyl)-6H-indolo[2,3-b]quinoxaline; autoimmune diseases |
| 09/15/2009 | US7589086 Substituted pyrazolo[3,4-D]pyrimidines as anti-tumor agents |
| 09/15/2009 | US7589068 Inhibitors of Akt activity |
| 09/15/2009 | CA2524709C Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 09/15/2009 | CA2461565C Process for making carbapenem compounds |
| 09/15/2009 | CA2440650C Photosensitizer and method for production thereof |
| 09/15/2009 | CA2400155C A novel crystalline form of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and process therefor |
| 09/15/2009 | CA2366600C A process for the preparation of 1,4,7,10-tetraazacyclododecane |
| 09/15/2009 | CA2274204C Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole] |
| 09/11/2009 | WO2009111547A1 7h-pyrrolo[2,3-h]quinazoline compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis |
| 09/11/2009 | WO2009111531A1 Pyrrolotriazine kinase inhibitors |
| 09/11/2009 | WO2009111501A1 Derivatives of imidazo [4, 5-d] pyridazine and their use as anti-viral compounds |
| 09/11/2009 | WO2009111449A1 1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo [4,3-e] -1,2,4-triazolo [4,3-c] pyrimidin-3-one compounds for use as adenosine a2a receptor antagonists |
| 09/11/2009 | WO2009111260A1 Phenylsulfonamide-substituted, pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof |
| 09/11/2009 | WO2009110556A1 Azo compound, azo pigment, and dispersion, colored composition, ink-jet recording ink, ink-get recording ink tank, ink-jet recording method and recorded material each containing the azo compound or the azo pigment |
| 09/11/2009 | WO2009110555A1 Azo compound, azo pigment, and dispersion, colored composition, ink-jet recording ink, ink-get recording ink tank, ink-jet recording method and recorded material each containing the azo compound or the azo pigment |
| 09/11/2009 | WO2009109986A1 Chalcone linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 09/11/2009 | WO2009109984A1 Quinazoline linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof' |
| 09/11/2009 | WO2009067541A3 Integrase inhibitors |
| 09/11/2009 | WO2009026446A3 Hdac inhibitors |
| 09/11/2009 | WO2007130927A3 Condensed tricyclic compounds as cgrp-receptor antagonists |
| 09/11/2009 | CA2717835A1 Azo compound, azo pigment, dispersion containing the azo compound or azo pigment, coloring composition, ink for inkjet recording, ink tank for inkjet recording, inkjet recording method and recorded material |
| 09/11/2009 | CA2717706A1 Azo compounds, azo pigments, and dispersion, coloring composition and ink for inkjet recording containing the azo compounds or azo pigments, ink tank for inkjet recording, inkjet recording method, and recorded products |
| 09/11/2009 | CA2717172A1 1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo [4,3-e] -1,2,4-triazolo [4,3-c] pyrimidin-3-one compounds for use as adenosine a2a receptor antagonists |
| 09/11/2009 | CA2625306A1 Electron acceptors-cored regioregular oligothiophenes as building blocks for soluble low band-gap conjugated polymers |
| 09/10/2009 | US20090227803 Process for the preparation of asenapine and intermediate products used in said process |
| 09/10/2009 | US20090227789 Ethylenediamine derivatives |
| 09/10/2009 | US20090227607 Deazapurines useful as inhibitors of janus kinases |
| 09/10/2009 | US20090227597 Pyrazolopyrimidinones as phosphodiesterase inhibitors |
| 09/10/2009 | US20090227575 7H-PYRROLO[2,3-H]QUINAZOLINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESIS |
| 09/10/2009 | US20090227567 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 09/10/2009 | US20090227565 Biphenyl Vasopressin Agonists |
| 09/10/2009 | US20090227555 Novel Pyridine Compounds |
| 09/10/2009 | US20090226948 Enzyme-based time temperature indicator |
| 09/10/2009 | US20090226398 Anti-viral compounds, compositions, and methods of use |
| 09/10/2009 | US20090225585 Self-Contained Charge Storage Molecules for Use in Molecular Capacitors |
| 09/09/2009 | EP2098526A1 Nitrogen-containing bicyclic compounds active on chronic pain conditions |
| 09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/09/2009 | EP2097417A1 Novel aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase |
| 09/09/2009 | EP2097416A1 Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 09/09/2009 | EP2097374A2 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors |
| 09/09/2009 | EP1957488B1 3-amino-2-arylpropyl azaindoles and uses thereof |
| 09/09/2009 | EP1915376B1 6-phenyl-pyrazolopyrimidine-7-ylamine fungicides |
| 09/09/2009 | EP1809284A4 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/09/2009 | EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency |
| 09/09/2009 | EP1449833B1 Bisimide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition |
| 09/09/2009 | CN101528749A Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 09/09/2009 | CN101528748A Imidazopyridazines as PI3K lipid kinase inhibitors |
| 09/09/2009 | CN101528747A 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
| 09/09/2009 | CN101525351A Treatment process of glyphosate mother liquor |
| 09/09/2009 | CN101525337A Oxidative desulfurization catalysts binuclear/trinuclear cobalt phthalocyanine carboxylate and preparation methods thereof |
| 09/09/2009 | CN100539788C Use of a layer consisting of hydrophobic, linear or two-dimensional polycyclic aromatics as a barrier layer or an encapsulation and electric components constructed with a layer of this type and compri |
| 09/09/2009 | CN100539202C Photoelectric conversion device |
| 09/09/2009 | CN100537572C 6-(2-halogenphenyl)-triazolopyrimidines derivatives and their use as fungicide |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/08/2009 | US7586117 Field effect transistor and method of producing same |
| 09/08/2009 | US7585981 electrostatic shields, capacitors, cells, EMI shielding agents, chemical sensors, display elements, prevention of electrification, antirust agents, adhesives, textiles, antistatic paints; produced by oxidizing an indole derivative in a reaction solution containing an organic solvent |
| 09/08/2009 | US7585975 A group is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to three independent R3 groups. The invention also includes methods of using these compounds as type I receptor tyrosine kinase inhibitors and hyperproliferation diseases |